{"transactions":[{"id":1273795,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":83364,"kind":"person","name":"ABRAMS MICHAEL S","position":1,"cik":"0001497702","reported_name":"ABRAMS MICHAEL S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-11T17:00:05.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (\"Options\") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. The Options shall vest in three equal annual installments beginning on February 7, 2026."}],"balance_after":50000,"derivative":{"exercise_price":2.94,"expiration_date":"2035-02-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-003585","document":"form4-02112025_050201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497702/000141588925003585/form4-02112025_050201.xml","form_type":"4"}},{"id":1784615,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":83364,"kind":"person","name":"ABRAMS MICHAEL S","position":1,"cik":"0001497702","reported_name":"ABRAMS MICHAEL S","relationship":{"officer":true,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Warrants (right to buy)","published_at":"2023-09-08T17:47:59.000Z","date":"2023-08-31","kind":"grant","planned":false,"acquired":true,"shares":20584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The warrants were sold as part of a unit with the shares of common stock reported in Table I, at a price of $0.275 per share of common stock and accompanying warrant to purchase two shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrants are exercisable after the earlier of (A) the six-month anniversary after the date of issuance and (B) the date that a registration statement registering the shares underlying the warrants is declared effective."}],"balance_after":20584,"derivative":{"exercise_price":1,"expiration_date":"2028-08-31","underlying":"Common Stock","underlying_shares":20584},"source":{"system":"sec-edgar","filing":"0001437749-23-025515","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497702/000143774923025515/rdgdoc.xml","form_type":"4"}},{"id":1784614,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":83364,"kind":"person","name":"ABRAMS MICHAEL S","position":1,"cik":"0001497702","reported_name":"ABRAMS MICHAEL S","relationship":{"officer":true,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2023-09-08T17:47:59.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":10292,"price":0.275,"value":2830.3,"ownership":{"direct":true},"balance_after":10292,"source":{"system":"sec-edgar","filing":"0001437749-23-025515","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497702/000143774923025515/rdgdoc.xml","form_type":"4"}},{"id":2119977,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":83364,"kind":"person","name":"ABRAMS MICHAEL S","position":1,"cik":"0001497702","reported_name":"ABRAMS MICHAEL S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-10T21:49:08.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the \"Plan\"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable."}],"balance_after":900000,"derivative":{"exercise_price":0.0401,"expiration_date":"2032-11-10","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001415889-22-011308","document":"form4-11112022_021157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497702/000141588922011308/form4-11112022_021157.xml","form_type":"4"}},{"id":2209875,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":83364,"kind":"person","name":"ABRAMS MICHAEL S","position":1,"cik":"0001497702","reported_name":"ABRAMS MICHAEL S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Warrants","published_at":"2022-07-08T16:57:10.000Z","date":"2022-07-06","kind":"grant","acquired":true,"shares":724346,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of common stock, senior secured convertible notes (the \"Notes\") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the \"Offering\"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the \"Act\"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder."},{"field":"security","element":"securityTitle","label":"F3","text":"Conversion of the warrants is subject to certain beneficial ownership limitations."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock, senior secured convertible notes (the \"Notes\") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the \"Offering\"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the \"Act\"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Conversion of the warrants is subject to certain beneficial ownership limitations."}],"balance_after":724346,"derivative":{"exercise_price":0.0497,"exercise_date":"2022-07-06","expiration_date":"2027-07-06","underlying":"Common Stock","underlying_shares":724346},"source":{"system":"sec-edgar","filing":"0001415889-22-007598","document":"form4-07082022_010754.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1497702/000141588922007598/form4-07082022_010754.xml","form_type":"4"}},{"id":2209874,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":83364,"kind":"person","name":"ABRAMS MICHAEL S","position":1,"cik":"0001497702","reported_name":"ABRAMS MICHAEL S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Senior Secured Convertible Notes","published_at":"2022-07-08T16:57:10.000Z","date":"2022-07-06","kind":"grant","acquired":true,"shares":36000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of common stock, senior secured convertible notes (the \"Notes\") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the \"Offering\"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the \"Act\"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder."},{"field":"security","element":"securityTitle","label":"F2","text":"The Notes become due and payable on January 6, 2024, bear interest at a rate of 10% per annum, are convertible at the option of the holder pursuant to certain provisions with an initial conversion price of $0.0457, contain customary events of default and are subject to certain beneficial ownership limitations."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Notes become due and payable on January 6, 2024, bear interest at a rate of 10% per annum, are convertible at the option of the holder pursuant to certain provisions with an initial conversion price of $0.0457, contain customary events of default and are subject to certain beneficial ownership limitations."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock, senior secured convertible notes (the \"Notes\") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the \"Offering\"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the \"Act\"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Notes become due and payable on January 6, 2024, bear interest at a rate of 10% per annum, are convertible at the option of the holder pursuant to certain provisions with an initial conversion price of $0.0457, contain customary events of default and are subject to certain beneficial ownership limitations."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Notes become due and payable on January 6, 2024, bear interest at a rate of 10% per annum, are convertible at the option of the holder pursuant to certain provisions with an initial conversion price of $0.0457, contain customary events of default and are subject to certain beneficial ownership limitations."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Notes become due and payable on January 6, 2024, bear interest at a rate of 10% per annum, are convertible at the option of the holder pursuant to certain provisions with an initial conversion price of $0.0457, contain customary events of default and are subject to certain beneficial ownership limitations."}],"derivative":{"underlying":"Common Stock","underlying_shares":787746},"source":{"system":"sec-edgar","filing":"0001415889-22-007598","document":"form4-07082022_010754.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497702/000141588922007598/form4-07082022_010754.xml","form_type":"4"}},{"id":2209873,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":83364,"kind":"person","name":"ABRAMS MICHAEL S","position":1,"cik":"0001497702","reported_name":"ABRAMS MICHAEL S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-07-08T16:57:10.000Z","date":"2022-07-06","kind":"grant","acquired":true,"shares":108652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock, senior secured convertible notes (the \"Notes\") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the \"Offering\"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the \"Act\"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock, senior secured convertible notes (the \"Notes\") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the \"Offering\"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the \"Act\"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder."}],"balance_after":108652,"source":{"system":"sec-edgar","filing":"0001415889-22-007598","document":"form4-07082022_010754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497702/000141588922007598/form4-07082022_010754.xml","form_type":"4"}},{"id":2554374,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":83364,"kind":"person","name":"ABRAMS MICHAEL S","position":1,"cik":"0001497702","reported_name":"ABRAMS MICHAEL S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-01T08:17:54.000Z","date":"2021-09-27","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the \"Plan\"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable."}],"balance_after":350000,"derivative":{"exercise_price":0.1028,"expiration_date":"2031-09-26","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001104659-21-121636","document":"tm2129012d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497702/000110465921121636/tm2129012d4_4.xml","form_type":"4"}},{"id":4449047,"issuer":{"id":1006,"kind":"organization","name":"FITLIFE BRANDS, INC.","symbol":"FTLF"},"owners":[{"id":83364,"kind":"person","name":"ABRAMS MICHAEL S","position":1,"cik":"0001497702","reported_name":"ABRAMS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2017-02-14T20:43:00.000Z","date":"2016-01-16","kind":"tax_withholding","acquired":false,"shares":80518,"price":1.3,"value":104673.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares disposed to satisfy the Reporting Person's tax liability incurred by the vesting of a previously granted award."}],"balance_after":322482,"source":{"system":"sec-edgar","filing":"0001415889-17-000272","document":"form5-02142017_050249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497702/000141588917000272/form5-02142017_050249.xml","form_type":"5"}}]}